Keynote speakers

Fernando Albericio

Research Professor - University of Barcelona

Muthiah (Mano) Manoharan

Senior Vice President of Drug Discovery, Alnylam Pharmaceuticals

Sudhir Agrawal

Founder and president of ARNAY Sciences

Michal Lebl

Director of The Development Center, Institute of Organic Chemistry and Biochemistry of the Czechoslovak Academy of Sciences

All speakers

Aernout van Haarst

R&D innovation portfolio manager at Euroapi

Afaf El-Sagheer

University of Southampton

Alberto Dal Corso

Università degli Studi di Milano

Andrew Jamieson

Head of Chemical Biology and Organic Synthesis Founding Director and CSO of Keltic Pharma Therapeutics Mazumdar-Shaw Advanced Research Centre (ARC)

Anil Kane

Global head of technical and scientific affairs, pharma services, Thermo Fisher Scientific

Dave Garman

Proteinqure

David Hodgson

Durham University

Fabien Rousset

Polypeptide Group

Fernando Albericio

Research Professor - University of Barcelona

Hagen Cramer

Chief Technology Officer, Quralis

Hanson Chang

CS Bio

Jale Muslehiddinoglu

Founder and president of ARNAY Sciences

Jennifer Frommer

University of Oxford

Jiří Jiráček

Head of a senior research group

Kishore Hotha

Global Pharmaceutical Executive| Strategic Leadership | CDMO| Biotech| CRO |Talent Development |CMC Strategy| Commercialization |Analytical Development |Project Management

Luca Gherardi

University of Pisa

Marco Macis

Research & Development Manager for Peptides API at Fresenius Kabi

Michal Lebl

Director of The Development Center, Institute of Organic Chemistry and Biochemistry of the Czechoslovak Academy of Sciences

Muthiah (Mano) Manoharan

Senior Vice President of Drug Discovery, Alnylam Pharmaceuticals

Silvia Marchesan

University of Trieste

Sophie Corbet

EMEA TS&D Manager Bioprocessing chez DuPont

Sudhir Agrawal

Founder and president of ARNAY Sciences